Clinical Trial Update: A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of UB-621 for genital herpes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• UB-621 (UB-621)

Snippet

Sponsor: United BioPharma | Conditions: Genital Herpes | Phase 2 | Status: UNKNOWN